Middle income vs Nauru: Immunization, measles (% of children ages 12-23 months)
Middle income
87.5%
in 2024
Nauru
98.0%
in 2024
Middle income rank
21st
Nauru rank
20th
Immunization, measles (% of children ages 12-23 months) over time
- Middle income
- Nauru
How they compare
Nauru currently reports 98.0% against 87.5% in Middle income, a difference of 10.5%.
That makes Nauru's figure about 1.1 times Middle income's.
The two have swapped places 4 times across 28 shared years of data; in 1997 it was Nauru ahead.
Middle income ranks 21st and Nauru ranks 20th of 47 groups.
Across the 4 decades both report, Middle income averaged higher in 1 and Nauru in 3.
Head to head by decade
| Decade | Middle income | Nauru | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 71.7% | 79.3% | 7.6% | Nauru |
| 2000s | 76.7% | 73.9% | 2.8% | Middle income |
| 2010s | 86.2% | 97.4% | 11.2% | Nauru |
| 2020s | 86.0% | 98.0% | 12.0% | Nauru |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, measles, Middle income or Nauru?
- Nauru, at 98.0% against 87.5% in Middle income as of 2024.
- What is the difference in immunization, measles between Middle income and Nauru?
- 10.5%, with Nauru ahead.
- How many years of comparable data are there for Middle income and Nauru?
- 28 years are reported by both, from 1997 to 2024.
- How do Middle income and Nauru rank globally for immunization, measles?
- Middle income ranks 21st and Nauru ranks 20th of 47 groups.
- Where does this data come from?
- World Health Organization (WHO), published as Immunization, measles (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, measles, measures the percentage of children ages 12-23 months who received the measles vaccination before 12 months or at any time before the survey. A child is considered adequately immunized against measles after receiving one dose of vaccine.